Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10401016 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Interferon Treatment for Patients With Chronic Hepatitis C and End Stage Renal Disease
Conditions: Chronic Hepatitis C;   End Stage Renal Disease
Interventions: Drug: Peginterferon alfa-2a;   Drug: Interferon alfa-2a

Indicates status has not been verified in more than two years